GlaxoSmithKline PLC enters the race to deliver the first home-use COVID-19 test available OTC in the US, working with a San Francisco biotech firm on a hand-held test to be submitted for regulatory approval before the end of the year.
The test GSK is developing with Mammoth Biosciences Inc. should deliver results in less than 20 minutes and will be submitted for FDA emergency use authorization (EUA)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?